Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 28, 2004Journal of NeuroscienceOpen Access

Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

LBLuigi BergamaschiniLuigi Sacco HospitalEREmanuela RossiUniversity of Milano-BicoccaCSClaudio StoriniTethys Research Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bergamaschini et al. (2004) studied this question.

synapsesocial.com/papers/6a1eb2456b4935698da43518https://doi.org/10.1523/jneurosci.0550-04.2004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heparin-binding Properties of the Amyloidogenic Peptides Aβ and Amylin1997 · 133 citations
  2. 2Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease2001 · 1,303 citations
  3. 3Aged Mice Exhibit Greater Mortality Concomitant to Increased Brain and Plasma TNF-α Levels following Intracerebroventricular Injection of Lipopolysaccharide2000 · 54 citations
  4. 4Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid2003 · 327 citations
  5. 5Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-β<i>In Vivo</i>by Immunotherapy2002 · 327 citations